Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:46 pm Unchanged | 2021-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | PERCEPTIVE ADVISORS LLC | 2,150,641 6.200% | 0 (Unchanged) | Filing History |
| 2022-02-14 3:45 pm Purchase | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | PERCEPTIVE ADVISORS LLC | 26,559,443 9.500% | 1,447,395 (+5.76%) | Filing History |
| 2022-02-14 3:45 pm Purchase | 2021-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX | PERCEPTIVE ADVISORS LLC | 9,903,879 17.000% | 1,200,000 (+13.79%) | Filing History |
| 2022-02-14 3:45 pm Sale | 2021-12-31 | 13G | DBV Technologies S.A. DBVT | PERCEPTIVE ADVISORS LLC | 0 0.000% | -442,212 (Position Closed) | Filing History |
| 2021-12-06 4:22 pm Purchase | 2021-11-23 | 13G | BELLUS Health Inc. BLU | PERCEPTIVE ADVISORS LLC | 4,741,354 6.100% | 4,741,354 (New Position) | Filing History |
| 2021-11-15 5:03 pm Purchase | 2021-11-03 | 13D | LianBio LIANY | PERCEPTIVE ADVISORS LLC | 56,319,960 53.500% | 56,319,960 (New Position) | Filing History |
| 2021-10-27 09:16 am Sale | 2021-10-22 | 13G | ADMA Biologics, Inc. ADMA | PERCEPTIVE ADVISORS LLC | 11,933,387 6.600% | -4,651,415 (-28.05%) | Filing History |
| 2021-10-22 5:02 pm Purchase | 2021-10-12 | 13G | IsoPlexis Corporation ISO | PERCEPTIVE ADVISORS LLC | 4,906,872 12.400% | 4,906,872 (New Position) | Filing History |
| 2021-09-17 5:08 pm Purchase | 2021-09-09 | 13G | Hancock Jaffe Laboratories HJLI | PERCEPTIVE ADVISORS LLC | 954,248 9.900% | 954,248 (New Position) | Filing History |
| 2021-08-25 5:04 pm Purchase | 2021-08-17 | 13G | VYNE Therapeutics Inc. VYNE | PERCEPTIVE ADVISORS LLC | 277,105 9.600% | 277,105 (New Position) | Filing History |
| 2021-06-25 5:01 pm Purchase | 2021-06-08 | 13D | Astria Therapeutics, Inc. ATXS | PERCEPTIVE ADVISORS LLC | 1,281,198 9.900% | 868,377 (+210.35%) | Filing History |
| 2021-06-21 5:00 pm Purchase | 2021-06-09 | 13D | Nautilus Biotechnology, Inc. NAUT | PERCEPTIVE ADVISORS LLC | 8,911,151 7.200% | 8,911,151 (New Position) | Filing History |
| 2021-05-03 5:21 pm Purchase | 2021-04-27 | 13G | Rain Enhancement Technologies Holdco Inc RAIN | PERCEPTIVE ADVISORS LLC | 2,537,019 13.900% | 2,537,019 (New Position) | Filing History |
| 2021-04-19 4:30 pm Sale | 2021-04-09 | 13G | Provention Bio, Inc. PRVB | PERCEPTIVE ADVISORS LLC | 3,633,023 5.700% | -591,366 (-14.00%) | Filing History |
| 2021-04-06 5:00 pm Unchanged | 2021-03-31 | 13D | Landos Biopharma, Inc. LABP | PERCEPTIVE ADVISORS LLC | 1,796,084 44.800% | 0 (Unchanged) | Filing History |
| 2021-03-26 5:00 pm Purchase | 2021-03-22 | 13G | Research Alliance Corp. II RACB | PERCEPTIVE ADVISORS LLC | 1,000,000 6.000% | 1,000,000 (New Position) | Filing History |